Analyst Reco.

Jun. 03 Autonomous Research Adjusts Price Target on CME to $328 From $326, Maintains Outperform Rating MT
Apr. 29 Autonomous Research Adjusts Price Target on CME Group to $326 From $344, Maintains Outperform Rating MT
Apr. 27 Rothschild & Co Redburn Adjusts Price Target on CME Group to $316 From $340, Maintains Neutral Rating MT
Apr. 23 CME Sees Record Volumes Offset by Pricing Pressure; Data Services Momentum Remains Strong, RBC Says MT
Apr. 23 CME Group Viewed as Strongest Liquidity Venue in Current Market, Morgan Stanley Says MT
Apr. 23 Barclays Adjusts Price Target on CME Group to $316 From $343, Maintains Equalweight Rating MT
Apr. 23 Deutsche Bank Lowers Price Target on CME Group to $322 From $342, Keeps Buy Rating MT
Apr. 23 Goldman Sachs Adjusts Price Target on CME Group to $267 From $275, Maintains Sell Rating MT
Apr. 23 Morgan Stanley Trims Price Target on CME Group to $353 From $362, Keeps Overweight Rating MT
Apr. 23 JPMorgan Adjusts Price Target on CME to $273 From $271, Maintains Underweight Rating MT
Apr. 23 TD Cowen Adjusts Price Target on CME to $323 From $340, Maintains Buy Rating MT
Apr. 23 Barclays Adjusts Price Target on CME to $316 From $343, Maintains Equalweight Rating MT
Apr. 16 JPMorgan Adjusts Price Target on CME Group to $271 From $266, Maintains Underweight Rating MT
Apr. 15 Piper Sandler Adjusts Price Target on CME Group to $329 From $313, Maintains Overweight Rating MT
Apr. 13 Rothschild & Co Redburn Adjusts CME Group Price Target to $340 From $347, Maintains Neutral Rating MT
Apr. 09 Jefferies Adjusts Price Target on CME Group to $349 From $356, Maintains Buy Rating MT
Apr. 09 TD Cowen Adjusts Price Target on CME to $340 From $328, Keeps Buy Rating MT
Apr. 08 Barclays Adjusts Price Target on CME Group to $344 From $312, Maintains Equalweight Rating MT
Apr. 07 Autonomous Research Adjusts Price Target on CME to $344 From $339, Maintains Outperform Rating MT
Apr. 06 Raymond James Adjusts Price Target on CME Group to $320 From $310, Maintains Outperform Rating MT
Mar. 16 Goldman Sachs Adjusts Price Target on CME to $275 From $266, Maintains Sell Rating MT
Mar. 12 Rothschild & Co Redburn Adjusts Price Target on CME to $347 From $333, Maintains Neutral Rating MT
Mar. 04 Argus Downgrades CME to Hold From Buy MT
Mar. 02 Jefferies Adjusts Price Target on CME Group to $356 From $302, Maintains Buy Rating MT
Feb. 12 Rothschild & Co Redburn Adjusts Price Target on CME Group to $333 From $300, Maintains Neutral Rating MT
No results for this search